Polyethylene Glycol Manufacturers and Suppliers in India
PEGylated Drugs Manufacturers in India
Shilpa Pharma is a leading polyethylene glycol manufacturer in India, specializing in the development and supply of high-quality PEG formulations for various therapeutic applications. With advanced R&D capabilities and GMP-compliant manufacturing facilities, we provide innovative PEGylation solutions that enhance drug stability, solubility, and pharmacokinetic profiles.
Our expertise spans both oncology and non-oncology drugs, delivering reliable, tailor-made PEGylated drug solutions for global pharmaceutical companies. Backed by strong knowledge in PEGylation chemistry, drug conjugation, and scalable production, Shilpa Pharma ensures high-quality products that meet international regulatory standards.
Committed to innovation, quality, and compliance, we support our clients with comprehensive documentation, IPR assistance, and global submission-ready data. With a focus on enhancing drug efficacy and patient outcomes, Shilpa Pharma stands as a trusted name among polyethylene glycol drug manufacturers in India.
For PEG drug enquiries, mail us at: info@shilpapharma.com
Complete Range of Polyethylene Glycol Pharmaceuticals
| PEGs for Pharma & Biomedical Applications | |||
|---|---|---|---|
| S. No. | Category Name | Molecular Weight (Mn) / PDI | Compound Description |
| 1 | Various Molecular weights of Methoxy PEG |
Mn: 3kDa, 5kDa, 10kDa, 20kDa with low PDI | — |
| 2 | Poly(2-ethyloxazoline) |
Average Mn: 3500–6500 (PDI ≤1.3), Average Mn:8500–12500 (PDI ≤1.4), Average Mn:17500–22500 (PDI ≤1.5) |
PEOZ is Amorphous, water-soluble, stable with temperature |
| 3 | Monodisperse PEG Diols (PEG6, PEG8, PEG9, PEG12) |
6, 8, 9, 12 kDa with low PDI | — |
| 4 | Poly(ethyleneimine hydrochloride) |
Average Mn:4000–7000 (PDI ≤1.5), Average Mn:8000–12000 (PDI ≤1.6), Average Mn:17000–22000 (PDI ≤1.6) |
High charge density, interacts with DNA; used in PEI & PEI-β-mPEG delivery vectors |
| 5 | Various Molecular weights of Methoxy PEG-block-Poly(ethyleneimine) |
Mn: 12, 25 kDa with low PDI | — |
| 6 | Linear Poly(ethyleneimine) |
Average Mn:2000–3000 (PDI ≤1.5), Average Mn:4000–6000 (PDI ≤1.6), Average Mn:7000–9000 (PDI ≤1.6) |
— |
| 7 | Various Molecular weights of Methoxy PEG-block-Poly(2-ethyloxazoline) |
Mn: 8, 20, 40 kDa with low PDI | — |
| 8 | Poly[2-(dialkylamino)ethyl methacrylate] derivatives |
Different derivatives shown (dimethylamino, diethylamino, diisopropylamino) | — |
| 9 | Various Molecular weights of Methoxy PEG-block-PLGA |
Various MW with low PDI | — |
Request a Quote for Pharma Polymers Today
Tailored Polymer Solutions
From synthesis to functionalization, we deliver polymers for advanced drug delivery and medical devices.
Advanced Drug Delivery Applications
Specialized PBD-b-PEO polymers for controlled release and targeted therapies.
Integrated R&D & GMP Manufacturing
State-of-the-art facilities ensure scalable, compliant, and high-quality polymer production.
Our Expertise at a Glance
Leading the Way in Pharma Innovation
1987
Established
100+
R&D workforce
1500+
Team size
3
Manufacturing site
100+
Audits
500+
Customers
100+
Projects
Serving Clients Across The Globe
Learn About Polyethylene Glycols
Polyethylene Glycol Manufacturers in India | Shilpa Pharma
In the growing chemical and pharmaceutical sectors, polyethylene glycol (PEG) plays a critical role in applications ranging from drug formulation to cosmetics and industrial processes. As demand for high-quality PEG increases, businesses are actively seeking reliable polyethylene glycol manufacturers in India who can meet global quality standards, ensure supply consistency, and offer competitive pricing.
Shilpa Pharma is among the leading PEG manufacturers in India, known for its strong manufacturing capabilities, stringent quality control, and customer-centric approach. We produce a wide range of polyethylene glycol grades that comply with pharmacopoeial standards (IP, BP, USP), making them suitable for both pharmaceutical and industrial use.
As experienced polyethylene glycol suppliers, we understand the critical needs of B2B clients—timely deliveries, consistent batch quality, regulatory documentation, and technical support. Our modern manufacturing facilities and commitment to innovation make Shilpa Pharma a preferred partner for businesses across sectors.
If you’re sourcing from polyethylene glycol manufacturers for bulk or contract supply, Shilpa Pharma offers a reliable, scalable, and quality-assured solution.
What is Polyethylene Glycol?
Polyethylene Glycol (PEG) is a polyether compound widely used across various industries for its versatility, solubility, and low toxicity. It is produced through the polymerization of ethylene oxide and is available in a range of molecular weights, which determines its physical form (liquid, semi-solid, or solid) and application.
In the pharmaceutical and healthcare industries, PEG is commonly used as a solvent, binder, and drug delivery agent. It enhances the solubility and bioavailability of active pharmaceutical ingredients (APIs), making it a key excipient in tablets, ointments, and injectable formulations.
Common Applications of PEG:
- Pharmaceutical formulations (laxatives, ointments, tablets)
- Personal care products (moisturizers, shampoos)
- Industrial uses (lubricants, coatings, surfactants)
- Food processing (as anti-foaming or coating agents)
Global Regulatory Approvals and Compliance
As a globally recognized Polyethylene Glycol supplier in India, Shilpa’s manufacturing facilities meet the highest international quality standards. The company holds approvals and certifications from several major regulatory bodies, ensuring consistent product quality and regulatory compliance.
Our facilities are:
- USFDA Approved (United States Food & Drug Administration)
- EU GMP Certified (European Union Good Manufacturing Practice)
- ANVISA Approved (Brazilian Health Regulatory Agency)
- COFEPRIS Approved (Mexico)
- TGA Certified (Australia)
- PMDA Approved (Japan)
- KFDA Certified (South Korea)
These certifications position Shilpa Pharma as a trusted partner for both regulated and semi-regulated markets.
Why Choose Shilpa PEGs Manufacturing in India?
When sourcing high-quality polyethylene glycols (PEGs), global businesses prioritize reliability, compliance, and consistency. Shilpa Pharma has established itself as a leading name in PEG manufacturing in India, combining technical expertise with strong manufacturing capabilities as a trusted Contract Development and Manufacturing Organization (CDMO).
Proven CDMO Capabilities
As an experienced CDMO, Shilpa Pharma partners with pharmaceutical, cosmetic, and industrial clients to deliver customized PEG solutions. From development to commercial production, our team supports clients through every stage, ensuring that formulations meet both functional needs and regulatory standards.
Our CDMO services include:
Custom PEG formulation and grade development
Scale-up from pilot to commercial batches
Regulatory support and documentation
Quality control aligned with USP, BP, IP standards
We go beyond manufacturing — we act as a strategic partner invested in your product’s success.
Trusted by Global Markets
Shilpa Pharma is the preferred PEG supplier for companies across China, Japan, Europe, and other international markets. This global trust is built on our consistent product quality, robust compliance framework, and responsive customer service.
Why international clients choose Shilpa Pharma:
High-purity PEGs for pharmaceutical and industrial use
Consistent quality and documentation
Scalable production capacity
On-time delivery and global logistics support
Our track record of international partnerships reflects our commitment to excellence and reliability.
Manufacturing Strength in India
Operating from India, Shilpa Pharma combines cost-effective manufacturing with state-of-the-art infrastructure. Our facilities are GMP-compliant and equipped to handle diverse molecular weights and specifications of polyethylene glycol, offering flexibility for both small and large-scale orders.